SUPN Supernus, Inc.

28.35USD-2.11%Mkt Cap: 5.89B USDP/E: —

Supernus, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United State…